Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Bruthans

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 4, 2020
Is There Really an Association of High Circulating Adiponectin Concentration and Mortality or Morbidity Risk in Stable Coronary Artery Disease?Otto Mayer, Jitka Seidlerová, Jan Bruthans, et al.
Clinical Biochemistry|August 6, 2014
The predictive potential of asymptomatic mild elevation of cardiac troponin I on mortality risk of stable patients with vascular diseaseOtto Mayer, Jitka Seidlerová, Jan Bruthans, et al.
European Journal of Internal Medicine|June 16, 2014
Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular diseaseOtto Mayer, Jitka Seidlerová, Jan Filipovský, et al.
Journal of Hypertension|August 10, 2020
ReplyPeter Wohlfahrt, Renata Cífková, Věra Lánská, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 17, 2022
High leptin status indicates an increased risk of mortality and heart failure in stable coronary artery diseaseOtto Mayer, Jan Bruthans, Jitka Seidlerová, et al.
European Journal of Internal Medicine|July 31, 2017
Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patientsOtto Mayer, Jan Bruthans, Jitka Seidlerová, et al.
Acta Cardiologica|April 4, 2019
The prognostic importance of subclinical heart failure in stable coronary heart disease patientsPetr König, Otto Mayer, Jan Bruthans, et al.
Journal of Hypertension|July 24, 2010
Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008Renata Cífková, Zdenka Skodová, Jan Bruthans, et al.
Atherosclerosis|May 18, 2010
Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICARenata Cífková, Zdenka Skodová, Jan Bruthans, et al.
International Journal of Cardiology|May 16, 2019
The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular diseaseOtto Mayer, Jitka Seidlerová, Václava Černá, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 4, 2020
Is There Really an Association of High Circulating Adiponectin Concentration and Mortality or Morbidity Risk in Stable Coronary Artery Disease?Otto Mayer, Jitka Seidlerová, Jan Bruthans, et al.
Clinical Biochemistry|August 6, 2014
The predictive potential of asymptomatic mild elevation of cardiac troponin I on mortality risk of stable patients with vascular diseaseOtto Mayer, Jitka Seidlerová, Jan Bruthans, et al.
European Journal of Internal Medicine|June 16, 2014
Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular diseaseOtto Mayer, Jitka Seidlerová, Jan Filipovský, et al.
Journal of Hypertension|August 10, 2020
ReplyPeter Wohlfahrt, Renata Cífková, Věra Lánská, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 17, 2022
High leptin status indicates an increased risk of mortality and heart failure in stable coronary artery diseaseOtto Mayer, Jan Bruthans, Jitka Seidlerová, et al.
European Journal of Internal Medicine|July 31, 2017
Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patientsOtto Mayer, Jan Bruthans, Jitka Seidlerová, et al.
Acta Cardiologica|April 4, 2019
The prognostic importance of subclinical heart failure in stable coronary heart disease patientsPetr König, Otto Mayer, Jan Bruthans, et al.
Journal of Hypertension|July 24, 2010
Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008Renata Cífková, Zdenka Skodová, Jan Bruthans, et al.
Atherosclerosis|May 18, 2010
Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICARenata Cífková, Zdenka Skodová, Jan Bruthans, et al.
International Journal of Cardiology|May 16, 2019
The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular diseaseOtto Mayer, Jitka Seidlerová, Václava Černá, et al.
Pageof 10